immunotherapyCurative-intent multimodality treatmentsystemic therapyadjuvant chemoimmunotherapyneoadjuvant and perioperative chemoimmunotherapystage II–III NSCLCNSCLCtyrosine kinase inhibitors
… in navigating these complex treatment choices.We conclude that immunotherapy and targeted agents have irrevocably altered curative-intent NS…